BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 27886889)

  • 61. A Neurologist's Perspective on Understanding Myasthenia Gravis: Clinical Perspectives of Etiologic Factors, Diagnosis, and Preoperative Treatment.
    Mukharesh L; Kaminski HJ
    Thorac Surg Clin; 2019 May; 29(2):133-141. PubMed ID: 30927994
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Decompensating esophoria as the presenting feature of myasthenia gravis.
    Arblaster GE; Shipman TL; Pepper IM
    J AAPOS; 2009 Jun; 13(3):310-1. PubMed ID: 19395293
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Myasthenic syndromes.
    Farrugia ME
    J R Coll Physicians Edinb; 2011 Mar; 41(1):43-7; quiz 48. PubMed ID: 21365067
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Ocular myasthenia gravis: diagnostic aspects and evolution].
    de Entrambasaguas M; López-Bernabé R; López-Alemany M
    Rev Neurol; 2007 Apr 1-15; 44(7):397-403. PubMed ID: 17420965
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ocular myasthenia gravis.
    Lee AG
    Curr Opin Ophthalmol; 1996 Dec; 7(6):39-41. PubMed ID: 10166551
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diagnostic yields and clinical features of ocular myasthenia gravis.
    Kim H; Oh SY
    Medicine (Baltimore); 2021 Jun; 100(25):e26457. PubMed ID: 34160444
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosis.
    Allen JA; Scala S; Jones HR
    Muscle Nerve; 2010 Mar; 41(3):379-84. PubMed ID: 19918767
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Histopathologic study of extraocular muscles in thyroid-associated ophthalmopathy coexisting with ocular myasthenia gravis: a case report.
    Ma R; Cheng Y; Gan L; Zhou X; Qian J
    BMC Ophthalmol; 2020 Apr; 20(1):166. PubMed ID: 32321476
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Myasthenia gravis: treatments and remissions].
    Dunand M; Lalive PH; Vokatch N; Kuntzer T
    Rev Med Suisse; 2007 May; 3(110):1185-6, 1188-90. PubMed ID: 17564346
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Myasthenia gravis and autoantibodies: Pathophysiology of the different subtypes].
    Berrih-Aknin S; Le Panse R
    Rev Med Interne; 2014 Jul; 35(7):413-20. PubMed ID: 24156976
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Myasthenia gravis crisis.
    Bershad EM; Feen ES; Suarez JI
    South Med J; 2008 Jan; 101(1):63-9. PubMed ID: 18176295
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Myasthenia gravis.
    Linton DM; Philcox D
    Dis Mon; 1990 Nov; 36(11):593-637. PubMed ID: 2209357
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New treatment approaches to myasthenia gravis.
    Havard CW; Fonseca V
    Drugs; 1990 Jan; 39(1):66-73. PubMed ID: 2178913
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ophthalmologic manifestations in myasthenia gravis: presentation and prognosis.
    Akan O; Baysal-Kirac L
    Acta Neurol Belg; 2021 Oct; 121(5):1131-1140. PubMed ID: 33439450
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society.
    Melzer N; Ruck T; Fuhr P; Gold R; Hohlfeld R; Marx A; Melms A; Tackenberg B; Schalke B; Schneider-Gold C; Zimprich F; Meuth SG; Wiendl H
    J Neurol; 2016 Aug; 263(8):1473-94. PubMed ID: 26886206
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Myasthenia and the neuromuscular junction.
    Gilhus NE
    Curr Opin Neurol; 2012 Oct; 25(5):523-9. PubMed ID: 22892950
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation.
    Le Panse R; Berrih-Aknin S
    Curr Opin Neurol; 2013 Oct; 26(5):569-76. PubMed ID: 23995274
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An atypical course of myasthenia gravis.
    Labana SS; Qureshi S; Nandakumar T; Cervellione KL; Venkatraman GK; Thakore H; Gintautas J
    Proc West Pharmacol Soc; 2007; 50():140-2. PubMed ID: 18605252
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Effectiveness of plasmapheresis in adolescent myasthenia gravis treatment].
    Kroczka S; Pietrzyk JA; Steczkowska M; Skowronek-Bała B
    Przegl Lek; 2010; 67(11):1213-6. PubMed ID: 21442979
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.